Comparison of Injection Techniques in Carpal Tunnel Syndrome

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 5, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions
Carpal Tunnel Syndrome
Interventions
DRUG

5% Dextrose

Ultrasound-guided hydrodissection is performed using a 12 MHz linear transducer (GE Logiq P9, GE Healthcare) via an in-plane ulnar approach under sterile conditions. 2.5 ml of 5% dextrose will be injected via an in-plane ulnar approach to mechanically separate the median nerve from the transverse carpal ligament. Subsequently, an additional 2.5 ml of 5% dextrose will be administered to separate the nerve from adjacent flexor tendons. The total injection volume will be 5 ml.

DRUG

Betamethasone and local anesthetic

Ultrasound-guided perineural injection is performed using a 12 MHz linear transducer (GE Logiq P9, GE Healthcare) via an in-plane ulnar approach under sterile conditions. A total of 2 ml solution (1 ml betamethasone and 1 ml 2% lidocaine) is injected perineurally around the median nerve under ultrasound guidance at the scaphoid-pisiform level.

Trial Locations (1)

06370

Etlik City Hospital, Ankara

All Listed Sponsors
lead

Ankara Etlik City Hospital

OTHER_GOV